Acute Toxicity Testing and LD50

Acute toxicity testing characterises the adverse effects produced by a single exposure, or by several exposures within a short period (conventionally up to 24 hours), to a substance. Its classical metric is the LD50, the dose estimated to be lethal to half of a test population, although contemporary guidelines have largely moved away from generating a precise LD50 toward methods that use far fewer animals.

Definition

Acute toxicity testing is the assessment of adverse effects occurring after a single or short-term exposure to a substance; the LD50 (median lethal dose) is a statistically estimated dose expected to cause death in 50% of an exposed population, historically used to express acute lethal potency.

Scope

The entry covers the concept and history of the LD50, the move from lethality-focused designs to procedures such as the up-and-down and fixed-dose methods, the use of acute data in hazard classification, and the limitations of single-exposure testing. It is a methodological topic and does not provide testing protocols, exposure thresholds, or poisoning-management guidance for specific substances.

Core questions

• What adverse effects, including death, follow a single or short-term exposure?
• What dose level marks the onset of serious acute toxicity?
• How can acute potency be estimated while minimising animal use and suffering?
• How do acute test results feed hazard classification and labelling?

Key concepts

• Median lethal dose (LD50)
• Dose-response curve and its slope
• Up-and-down procedure
• Fixed-dose procedure
• Acute toxic class method
• Route of exposure (oral, dermal, inhalation)
• Hazard classification (GHS categories)

Mechanisms

Acute testing exposes animals once and observes the resulting effects over a defined period. In the classical approach, graded doses are administered to groups and the proportion responding is fitted to a dose-response model to estimate the LD50 and the slope of the curve, as formalised by Trevan. Modern sequential designs, such as the up-and-down procedure, instead adjust the dose for each successive animal based on the previous outcome, converging on an estimate of lethal potency with markedly fewer animals; fixed-dose and acute toxic class methods similarly use predefined dose levels and signs short of death to assign a hazard category rather than a precise LD50.

Clinical relevance

Acute toxicity data inform the hazard classification, labelling, and safe-handling information attached to chemicals and medicinal products, and they describe the kind of effects that a large single exposure can produce. The entry explains how such data are generated and is descriptive only; it is not a basis for managing exposures or poisoning in individuals.

Evidence & guidelines

Acute oral toxicity testing is governed by harmonised OECD test guidelines, including the up-and-down procedure (TG 425), the fixed-dose procedure (TG 420), and the acute toxic class method (TG 423), which together largely replaced the conventional LD50 test (former TG 401). Results are mapped to internationally harmonised hazard categories under the Globally Harmonised System (GHS). These guidelines are periodically revised, and the trend has been toward designs that reduce animal numbers and reliance on lethality as the endpoint.

History

The LD50 was introduced by J. W. Trevan in 1927 as a way to quantify the inherent variability of biological responses to toxic doses, and it became the standard expression of acute lethal potency for much of the twentieth century. Growing scientific and ethical criticism of testing built around animal death drove the development of refined sequential and fixed-dose designs in the 1980s and after, exemplified by Bruce's up-and-down procedure, and culminated in the deletion of the conventional LD50 guideline in favour of methods that use fewer animals.

Debates

Is the precise LD50 a meaningful regulatory endpoint?

Critics argue that a single lethality figure is highly variable between laboratories and species and offers little mechanistic insight, motivating its replacement by classification-oriented methods; the resulting categories are coarser but use far fewer animals.

Key figures

• John William Trevan
• Robert D. Bruce
• Thomas Hartung

Seminal works

• trevan-1927
• bruce-1985
• oecd-tg425-2022

Frequently asked questions

Is the LD50 still measured today?

A precise LD50 is rarely the goal now. Current guidelines use sequential or fixed-dose designs that estimate a hazard category with far fewer animals, and the conventional LD50 test guideline has been withdrawn.

Why is acute toxicity expressed per unit body weight?

Doses are expressed as amount per unit body weight (for example mg/kg) so that potency can be compared across animals and species of different sizes; this is a convention of the test, not a recommendation for any exposure level.